Species M. avium-intracellulare M. malmoense M. kansasii M. xenopi M. chelonae M. fortuitum M. gordonae M. marinum M. abscessus M. peregrinum M. terrae M. szulgai M. fortuitum/chelonae group M. scrofulaceum M. flavescens Unnamed species Total Moore et al. BMC Public Health 2010, 10:612 http://www.biomedcentral.com/1471-2458/10/612 Page 3 of 6 Table 1 Non-tuberculous mycobacteria reports and rates by species, England, Wales and Northern Ireland, 1995, 2000, 2006 1995 2000 2006 Number Number Rate per 100,000 Rate per 100,000 Number Rate per 100,000 Total number (1995-2006) 225 101 71 33 5 6 1 14 0 0 0 1 0 0 0 2 459 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 360 145 129 50 42 27 12 27 1 0 2 0 0 1 0 5 801 0.7 0.3 0.2 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 649 130 152 117 117 90 153 27 60 30 4 1 4 1 0 73 1608 1.2 0.2 0.3 0.2 0.2 0.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.9 4732 1510 1380 827 708 518 516 274 172 69 33 30 23 15 1 231 11039 in both sexes, but mostly in people aged 65 and over (from 0.7 per 100,000 to 3.6 per 100,000 - Figure 2). The increase was also more pronounced in pulmonary sites, rising from 45% of reports (113/251) in 1995 to 80% (603/757) in 2006. The percentage of reports from blood specimens declined from 28% (71/251) to 3% (21/ 757) in the same period. Useful clinical comments were available for just 8% (363/4732) of reports. Of these, HIV/AIDS, chronic respiratory illness, cystic fibrosis and cancer were Figure 1 Rates of non-tuberculous mycobacteria reports (selected species), England, Wales and Northern Ireland, 1995-2006.